In Australia, CSL Seqirus is one of the largest influenza vaccine providers, a leader in iron deficiency and has a rapidly growing presence in nephrology. We are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.

CSL Seqirus is proud to sponsor local medical education and invest in research and development to help patients lead better, healthier lives.